HORIZON THERAPEUTICS
Summary
Horizon Therapeutics operates as a biopharmaceutical company. The Company develops, acquires, and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation as well as specialty and orphan diseases.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 25.12 B
Avg. Deal Size£ 12.56 B
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
